News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Features Subtherapeutic Heparin: As Stories Multiply, Concerns Mount Yael L. Maxwell November 27, 2019
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018
News Features Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives Yael L. Maxwell January 12, 2018
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Features La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir Todd Neale November 08, 2015